We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

IL-15R alpha Products

Antibodies
ELISA Kits
Mouse IL-15R alpha DuoSet ELI ...
Mouse IL-15R alpha DuoSet ELISA, 1...
DY551
Species: Mu
Applications: ELISA
Lysates
IL-15R alpha Overexpression L ...
IL-15R alpha Overexpression Lysate
NBL1-11910
Species: Hu
Applications: WB
IL-15R alpha Overexpression L ...
IL-15R alpha Overexpression Lysate
NBL1-11909
Species: Hu
Applications: WB
Proteins
Recombinant Mouse IL-15R alph ...
Recombinant Mouse IL-15R alpha Fc ...
551-MR
Species: Mu
Applications: Bioactivity
Formulation Catalog # Availability Price  
Recombinant Human IL-15R alph ...
Recombinant Human IL-15R alpha Fc ...
147-IR
Species: Hu
Applications: Bioactivity
Formulation Catalog # Availability Price  
Recombinant Human IL-15R alph ...
Recombinant Human IL-15R alpha Fc ...
7194-IR
Species: Hu
Applications: Bioactivity
Formulation Catalog # Availability Price  

Description

Interleukin 15 Receptor alpha (IL‑15 R alpha ), also known as CD215, is a widely expressed 60-kDa transmembrane glycoprotein that plays an important role in the homeostasis and activation of NK cells and CD8+ memory T cells and participates in the development and function of many other hematopoietic cell types and non‑immune cell types (1‑3). Mature human IL‑15 R alpha consists of a 175 amino acid (aa) extracellular domain (ECD) containing one N‑linked glycosylation site, a 23 aa transmembrane segment, and a 39 aa cytoplasmic tail (4). Within the ECD, human IL‑15 R alpha shares approximately 60% aa sequence identity with mouse and rat IL‑15 R alpha. Alternate splicing of human IL‑15 R alpha generates additional isoforms with variable length deletions in the ECD and/or substitutions in the cytoplasmic domain (4, 5). IL‑15 R alpha binds to Interleukin‑15 with high affinity (6). IL‑15 additionally interacts with lower affinity to a complex of IL‑2 R beta and the common gamma chain ( gamma c) which are also subunits of the IL‑2 receptor complex (7, 8). The use of shared receptor components contributes to the overlapping biological effects of IL‑15 and IL‑2. The dominant mechanism of IL‑15 action is known as transpresentation in which IL‑15/IL‑15 R alpha complexes are expressed on the surface of one cell and interact with complexes of IL‑2 R beta / gamma c on adjacent cells (9). This enables cells to respond to IL‑15 even if they do not express IL‑15 R alpha (10‑12). IL‑15/IL‑15 R alpha complexes can transmit reverse signaling that promotes cellular adhesion, tyrosine phosphorylation of intracellular proteins, and cytokine secretion by the IL‑15/IL‑15 R alpha expressing cells (13, 14). Shed soluble forms of IL‑15 R alpha retain the ability to bind tightly to IL‑15 and can inhibit IL‑15 bioactivity (6, 15, 16). Our Avi-tag Biotinylated Recombinant Human IL‑15 R alpha features biotinylation at a single site contained within the Avi-tag, a unique 15 amino acid peptide. Protein orientation will be uniform when bound to streptavidin-coated surface due to the precise control of biotinylation and the rest of the protein is unchanged so there is no interference in the protein's bioactivity.

Bioinformatics

Uniprot
Product By Gene ID 3601
Alternate Names
  • CD215 antigen
  • CD215
  • IL15 R alpha
  • IL-15 R alpha
  • IL-15 receptor subunit alpha
  • IL-15R alpha
  • IL15RA
  • IL-15Ra
  • IL-15R-alpha
  • interleukin 15 receptor, alpha
  • interleukin-15 receptor subunit alpha
  • MGC104179